Trending
Revolutionary Shows Promise 4
Revolutionary Shows Promise 3
Revolutionary Shows Promise 1
Revolutionary aids Treatment Shows Promise
Revolutionary Cancer Treatment Shows Promise
FDA Expands Approval of Vonvendi for von Willebrand Disease, Including Pediatric Use
Child Depression Fluctuations may trigger Parent Depression not vice versa: JAMA
Indoor Air Quality and Diet Found to Regulate Inflammation in Childhood: Study Finds
How Smoking Fuels Pancreatic Cancer Growth and Worsens Outcomes: Study Finds Out
Follow Us:
November 04, 2025

Get In Touch

Merck, Eisai to shut down late stage trial of liver cancer therapy Pharma News

Merck, Eisai to shut down late stage trial of liver cancer therapy

  • 31 October 2025
  • 3 days ago

Merck Keytruda wins European Commission nod for locally advanced head, neck squamous cell carcinoma Pharma News

Merck Keytruda wins European Commission nod for locally advanced head, neck squamous cell carcinoma

  • 30 October 2025
  • 4 days ago

Immunotherapy after surgery shows potential in preventing the spread of aggressive skin cancer: clinical trial Dermatology

Immunotherapy after surgery shows potential in preventing the spread of aggressive skin cancer: clinical trial

  • 22 October 2025
  • 1 week ago

Immunotherapy after surgery shows potential in preventing the spread of aggressive skin cancer Dermatology

Immunotherapy after surgery shows potential in preventing the spread of aggressive skin cancer

  • 22 October 2025
  • 1 week ago

MSD Pharma gets CDSCO panel nod for New Indications of Pembrolizumab in India Pharma News

MSD Pharma gets CDSCO panel nod for New Indications of Pembrolizumab in India

  • 04 October 2025
  • 4 weeks ago

Intas Pharma Told to Narrow Margins, Extend Duration in Pembrolizumab Trial Protocol Pharma News

Intas Pharma Told to Narrow Margins, Extend Duration in Pembrolizumab Trial Protocol

  • 30 September 2025
  • 1 month ago

Intas Pharma Told to Revise Phase I, III Pembrolizumab Trial Protocol Pharma News

Intas Pharma Told to Revise Phase I, III Pembrolizumab Trial Protocol

  • 24 September 2025
  • 1 month ago

Merck injectable version of blockbuster cancer therapy Keytruda gets USFDA approval Oncology

Merck injectable version of blockbuster cancer therapy Keytruda gets USFDA approval

  • 20 September 2025
  • 1 month ago

WHO Updates Essential Medicines List, Adds Cancer, Diabetes and Obesity Drugs Diabetes and Endocrinology

WHO Updates Essential Medicines List, Adds Cancer, Diabetes and Obesity Drugs

  • 09 September 2025
  • 1 month ago

Medical Bulletin 09/September/2025 Medicine News

Medical Bulletin 09/September/2025

  • 09 September 2025
  • 1 month ago

Recent News

Nanotechnology Reverses Alzheimer's Symptoms in Mi...

  • 03 November, 2025

Gum disease could silently cause serious brain dam...

  • 03 November, 2025

Can Early-Day Fasting Significantly Boost Metaboli...

  • 03 November, 2025

Delhi HC bars doctor from running medical centre d...

  • 03 November, 2025

Phase III data for Gazyva/Gazyvaro show significan...

  • 03 November, 2025

Daily Newsletter

Get all the top stories from Blogs to keep track.